Altis Biosystems
Ashley Carney has a diverse work experience, beginning in 2017 as an Undergraduate Researcher at the Biomechanical Environments Laboratory at Texas A&M University. In 2018, they were an SMART Intern at Texas Children's Hospital & Baylor College of Medicine, working on a novel ocular drug delivery system. In 2019, they were a Manufacturing and Quality Intern at Eli Lilly and Company, leading a cross functional project within manufacturing and process development. In 2020, they were a Scientist at Eli Lilly and Company, providing technical stewardship for primary packaging components for the commercial parenteral platform, leading container-closure and market product complaint investigations, and managing cross functional project teams to implement continuous improvement projects. Currently, Ashley Carney is an Associate Scientist and Research Associate at Altis Biosystems.
Ashley Carney attended Texas A&M University from 2016 to 2020, where they earned a Bachelor's degree in Biomedical Engineering.
This person is not in any offices
Altis Biosystems
Altis Biosystems is a spin-out company from the University of North Carolina at Chapel Hill and based in Durham, North Carolina. The intellectual property behind its stem cell platform was created as part of an NIH Transformative Research Award to develop a microfluidic organ-on-a-chip mimic of the human colon and awarded to Altis’ scientific founders.